Advanced search
Publication Cover
Current Medical Research and Opinion Volume 27, 2011 - Issue 2
Submit an article Journal homepage
139
Views
6
CrossRef citations to date
0
Altmetric
Original Article

RETRA: evaluating the transfusion rate with darbepoetin alfa 500 µg every 3 weeks in anaemic cancer patients receiving chemotherapy

W. Eisterer Medical University Innsbruck, Dept. Internal Medicine, AustriaCorrespondence[email protected]
,
C. Hussl Medical University Innsbruck, Dept. Internal Medicine, Austria
,
H. Erb Clinical Trials Management, Vienna, Austria
,
F. Haslbauer Vöcklabruck General Hospital, Dept. Internal Medicine 2, Austria
,
S. Sormann Medical University Graz, Dept Haematology, Austria
,
S. Braun Amgen Europe GmbH, Zug, Switzerland
&
C. Jaeger Amgen Austria GmbH, Medical Department, Vienna, Austria
 show all
Pages 355-363 | Accepted 18 Nov 2010, Published online: 20 Dec 2010

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

S. Van Belle, A. Swieboda-Sadlej, C. Karanikiotis, J.-L. Labourey, A. Galid, T. Wheeler, B. Pujol & J.G. Aerts. (2012) A final analysis from the CHOICE study examining darbepoetin alfa use for chemotherapy-induced anaemia in current European clinical practice. Current Medical Research and Opinion 28:7, pages 1079-1087.
Read now

Articles from other publishers (5)

Nataša Debeljak, Peter Solár & Arthur J. Sytkowski. (2014) Erythropoietin and Cancer: The Unintended Consequences of Anemia Correction. Frontiers in Immunology 5.
Crossref
Carol A. Forbes, Gillian Worthy, Julie Harker, Jos Kleijnen, Lucie Kutikova, Laurent Zelek & Simon Van Belle. (2014) Dose Efficiency of Erythropoiesis-Stimulating Agents for the Treatment of Patients With Chemotherapy-Induced Anemia: A Systematic Review. Clinical Therapeutics 36:4, pages 594-610.e4.
Crossref
Robert Pirker, Melissa Pirolli, Jane Quigley, Scott Hulnick, Jason Legg, Helen Collins & Johan Vansteenkiste. (2012) Hemoglobin decline in cancer patients receiving chemotherapy without an erythropoiesis-stimulating agent. Supportive Care in Cancer 21:4, pages 987-992.
Crossref
Melike Deger, Wolfgang Eisterer, Lucie Kutikova & Sam Salek. (2012) Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe. Supportive Care in Cancer 21:2, pages 485-493.
Crossref
Jean-Luc Canon, Johan Vansteenkiste, Michael Hedenus, Pere Gascon, Carsten Bokemeyer, Heinz Ludwig, Jan Vermorken, Jason Legg, Beatriz Pujol & Ken Bridges. (2011) Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9?g/dL versus 9 to <10?g/dL versus ?10?g/dL: an exploratory analysis of a phase 3 trial. Medical Oncology 29:3, pages 2291-2299.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.